Investors / United States / Nodenza Venture Partners
Nodenza Venture Partners
Venture capital · New York, NY, United States · North America
Nodenza Venture Partners is a life sciences investment firm established by a team of experienced life sciences entrepreneurs, founders and leaders. It invests in disruptive technologies and therapies and targets the clinical and product launch value inflection points of the life sciences value chain.
Invests inHealthcare & Biotech
In its own wordslife sciencestherapeuticsmedical deviceshealthcarebiotech
Your fit with Nodenza Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNodenza Venture Partners lists 1 checked portfolio company on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside AMR Action Fund, Easton Capital and New Science Ventures.
No funding round on record names Nodenza Venture Partners yet, so the figures come from its portfolio page.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| AMR Action Fund | 1 |
| Easton Capital | 1 |
| New Science Ventures | 1 |
| Western Technology Investment | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Nodenza Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
1 company checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company is developing human antibodies to break down bacterial biofilms and help antibiotics treat persistent infections. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- nodenza.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 1
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Nodenza Venture Partners' profile as data
Pull Nodenza Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/nodenza.com
# also
GET /v1/firms/nodenza.com/portfolio
GET /v1/firms/nodenza.com/coinvestors
GET /v1/firms/nodenza.com/news